Hyperbilirubinemia during Atazanavir treatment in HIV/AIDS patients taking second line ART drugs

Abstract

Background Hyperbilirubinemia is frequently observed in HIV (Human Immunodeficiency Virus) patients treated with Atazanavir containing antiretroviral regimen in the dose of 300 mg once daily. However, little is known about the incidence of Atazanavir-associated hyperbilirubinemia in Asian population. Hyperbilirubinemia is defined as an excess of bilirubin in blood either conjugated or unconjugated. Aim To estimate the incidence of Atazanavir associated hyperbilirubinemia in HIV patients receiving second line antiretroviral regimen advocated by National AIDS Control Organisation (NACO) by measuring serum bilirubin levels. Materials and Methods The study was done in 100 HIV-infected patients attending ART Plus centre at a tertiary care centre receiving Atazanavir regimen for a period of 12 months. The bilirubin levels in blood were estimated by MALOY & EVELYN METHOD. Results The incidence of grade I hyperbilirubinemia was 26%, grade II was 24%, grade III was 48% & grade IV 2%. The Study data suggested that Atazanavir-associated hyperbilirubinemia is common and self limiting. Conclusion It was observed that most of the HIV/AIDS patients receiving Atazanavir containing ART regimens developed hyperbilirubinemia, so these patients should be regularly monitored for Atazanavir induced hyperbilirubinemia.

Authors and Affiliations

Savithri Desai

Keywords

Related Articles

Synbiotics vs probiotics in pediatrics – an interventional study

Background Probiotics are live bacteria which are intended to colonize the large intestine and confer physiological health benefits to the host. Prebiotics are food or dietary supplement product that confers a health ben...

An overview on facts and myths on aging and prevention of anti-aging

ABSTRACT The „anti-ageing‟ movement claims many unprecedented features to combat the symptoms of ageing, to slow down the ageing process, to enhance health and vitality, to increase life expectancy and ultimately to impr...

Screening of Mentha cordifolia Opiz (Yerba Buena) buffer crude extract for aspartyl protease pepsin inhibitory activity

To date, several hundred bioactive compounds have been isolated from plant sources. Among them, protease inhibitors have drawn the attention recently owing to their pivotal role in pharmaceutical industry. With the ant...

Phytochemical screening and in-vivo evalution of anti diabetic studies of an ayurvedic herbo mineral formulation trushanaadiloha.

The Herbomineral formulation Trushanadi loha is a mixture of fourteen drugs. All drugs used in this formulation are from different parts of plant sources. The mixture of different 14 drugs was extracted with aqueous and...

Anti microbial activity of Ocimum basilicum and Achyranthes aspera

The aim of the study was to investigate antibacterial and antifungal activity of plant extract taken from two different plants, Achyranthes aspera Linn., and Ocimum basilicum against Streptomyces fulvissimus, Klebsiella...

Download PDF file
  • EP ID EP413190
  • DOI -
  • Views 109
  • Downloads 0

How To Cite

Savithri Desai (2018). Hyperbilirubinemia during Atazanavir treatment in HIV/AIDS patients taking second line ART drugs. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 7(1), 1-6. https://europub.co.uk/articles/-A-413190